QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

SLN

QT64Silence Therapeutics plc
NASDAQ·Healthcare·Biotechnology·UK
Latest market price
6.93
+0.17+2.51%
OverviewShort InterestFilings
SLNQT64Silence Therapeutics plc·NASDAQ
OverviewShort InterestFilings
6.93+2.51%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-1.96
Insider Own-
Shs Outstand-
Perf Week3.74%
Market Cap319.30MForward P/E-EPS next Y-0.58Insider Trans-Shs Float-Perf Month20.10%
Enterprise Value313.78MPEG0.13EPS next Q-0.14Inst Own-Short Float-Perf Quarter8.62%
Income-85157707.00P/S346.51EPS this Y72.37%Inst Trans-Short Ratio-Perf Half Y10.53%
Sales921.49KP/B6.46EPS next Y-7.54%ROA-73.98%Short Interest-Perf YTD13.98%
Book/sh-P/C-EPS next 5Y-ROE-121.71%52W High8.40 -17.50%Perf Year29.05%
Cash/sh-P/FCF-EPS past 3/5Y-ROIC-82.66%52W Low4.19 65.39%Perf 3Y-
Dividend Est.-EV/EBITDA-4.02Sales past 3/5Y-61.84% -27.52%Gross Margin66.43%Volatility4.95% 5.69%Perf 5Y-
Dividend TTM-EV/Sales340.51EPS Y/Y TTM34.18%Oper. Margin-9396.64%ATR (14)0.55Perf 10Y-
Dividend Ex-Date-Quick Ratio9.83Sales Y/Y TTM-2.33%Profit Margin-9243.05%RSI (14)54.74Recom2.40
Dividend Gr. 3/5Y-Current Ratio9.83EPS Q/Q46.67%SMA205.62%Beta1.41Target Price57.00
Payout0.00%Debt/Eq0.00Sales Q/Q-SMA501.42%Rel Volume1.24Prev Close6.76
Employees116LT Debt/Eq-EarningsAug 06SMA20013.81%Avg Volume308.09KPrice6.93
IPO DateSep 08, 2020Option/ShortYes / YesEPS/Sales Surpr.3.03% -100.00%Net Debt/EBITDA0.07Volume382,922Change2.51%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-28-24ReiteratedMorgan StanleyOverweight$18 → $49
Jun-28-24ReiteratedChardan CapitalBuy$29 → $55
Mar-13-24ReiteratedBMO Capital$67
Dec-09-22ReiteratedMorgan StanleyEqual Weight$18
Nov-17-22ReiteratedChardan CapitalBuy$29
Latest News
Jun-17-26
Jun-17-2603:16PM
How Silence Therapeutics (SLN) Is Building the Divesiran Case Around Fewer Blood Draws in Polycythemia VeraYahoo
08:03AM
Sophia Genetics, Ormat Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market SessionBenzinga
06:16AM
HC Wainwright & Co. Reiterates Buy on Silence Therapeutics, Maintains $75 Price TargetBenzinga
Jun-15-26
Jun-15-2603:09PM
European Equities Traded in the US as American Depositary Receipts Surge in Monday TradingYahoo
Jun-12-26
Jun-12-2604:26PM
Silence: 'Buy' Zerlasiran Program Shift And Divesiran Results August 2026SeekingAlpha
03:14PM
European Equities Traded in the US as American Depositary Receipts Increase in Friday Trading; Rise for WeekYahoo
10:47AM
Silence Therapeutics Stock Rises On Positive Blood Cancer Drug DataBenzinga
Jun-11-26
Jun-11-2603:09PM
European Equities Traded in US as ADRs Rise in Thursday TradingYahoo
01:20PM
Silence Therapeutics Presents Follow-Up, Quality-Of-Life Data From Phase 1 SANRECO Study Evaluating Divesiran In 21 Phlebotomy-Dependent Patients With Polycythemia Vera At EHA 2026 Annual Congress.Benzinga
11:30AM
Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia VeraYahoo
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue42143
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A11012
Gross Profit32031
Selling, General and Administrative Excl. Other232227
Research and Development586868
Other Operating Expense000
Operating Income-50-90-63
Interest Expense
-300
Unusual Expense
———
Non-Operating Income (Expense)-14-1-14
Net Income Before Taxes-25-89-44
Income Taxes501
Consolidated Net Income-31-89-45
Net Income From Continuing Operations-31-89-45
Net Income-31-89-45
EPS (Recurring)-1.96-1.89-2.37
EPS (Basic, Before Extraordinaries)-1.96-1.89-2.37
EPS (Diluted)-1.96-1.89-2.37
EBITDA-34-88-49
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio2.64285.76—
Gross Margin76.190.0072.09
Operating Margin-119.05-9,000.00-146.51
Net Margin-73.81-8,900.00-104.65
Shares Outstanding164715
Market Capitalization111286—
Operating Lease Expense
———
Insider Trading Volume
$7.44$6.73$6.02$5.31$4.60● Close Price0.00M0.43M0.86M1.30M1.73MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Griffiths Richard Ian10% OwnerOct 27 '25Sale7.752,00015,50011,819,861Feb 13 12:00 AM
Griffiths Richard Ian10% OwnerOct 27 '25Buy7.752,00015,50011,825,861Feb 13 12:00 AM
Griffiths Richard Ian10% OwnerAug 03 '25Sale5.4520,000109,00011,805,861Feb 13 12:00 AM
Griffiths Richard Ian10% OwnerAug 03 '25Buy5.4520,000109,00011,825,861Feb 13 12:00 AM
Griffiths Richard Ian10% OwnerAug 01 '25Buy6.144,03424,76911,825,861Aug 04 12:00 AM
Griffiths Richard Ian10% OwnerJul 31 '25Buy6.1814,34288,63411,821,827Aug 04 12:00 AM
Griffiths Richard Ian10% OwnerJul 30 '25Buy6.148,92354,78711,807,485Jul 31 12:00 AM
Griffiths Richard Ian10% OwnerJul 29 '25Buy6.2014,55990,26611,798,562Jul 31 12:00 AM
Griffiths Richard Ian10% OwnerJul 22 '25Buy6.092,91017,72211,784,003Jul 23 12:00 AM
Griffiths Richard Ian10% OwnerJul 21 '25Buy6.0422,435135,50711,781,093Jul 23 12:00 AM
Griffiths Richard Ian10% OwnerJul 15 '25Buy6.4043,293277,07511,758,658Jul 16 12:00 AM
Griffiths Richard Ian10% OwnerJul 11 '25Buy6.4328,000180,04011,715,365Jul 16 12:00 AM
Griffiths Richard Ian10% OwnerJul 09 '25Buy6.0030,133180,79811,687,365Jul 10 12:00 AM
Griffiths Richard Ian10% OwnerJul 08 '25Buy5.9424,387144,85911,657,232Jul 10 12:00 AM
Griffiths Richard Ian10% OwnerJul 07 '25Buy5.657,93744,84411,632,845Jul 10 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR